DVR-01
CAS No. 330461-34-2
DVR-01( DVR 01 | DVR01 | 3-(azepan-1-ylsulfonyl)-N-benzyl-4-chlorobenzamide )
Catalog No. M27873 CAS No. 330461-34-2
DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 500MG | 3348 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDVR-01
-
NoteResearch use only, not for human use.
-
Brief DescriptionDVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
-
DescriptionDVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
-
In VitroDVR-01 (0-10 μM; 4 d) inhibits HBV in human hepatoma cells with EC50 values of 1.7 and 1.6 μM in AML12HBV10 and HepDES19 cells, respectively.DVR-01 (0.156-10 μM; 2 d) selectively disrupts the pgRNA encapsidation by HBV.DVR-01 (3 d) shows antiviral activity against hepadnaviruses in human hepatoma cells with EC50s of 2.899, >10 and >25 μM for HBV, WHV and DHBV, respectively.DVR-01 (0.0097-10 μM; 2 d) shows antiviral activity against drug-resistant HBV mutants with EC50s of 2.899, 3.273, 3.180, 2.752, 2.567 and 2.403 μM for wt, rtL180 M/rtM204V, rtA181V, rtN236T, rtM204I and rtL180 M/rtM204V/rtT184G/rtS202I, respectively.
-
In Vivo——
-
SynonymsDVR 01 | DVR01 | 3-(azepan-1-ylsulfonyl)-N-benzyl-4-chlorobenzamide
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number330461-34-2
-
Formula Weight406.93
-
Molecular FormulaC20H23ClN2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1ccc(cc1S(=O)(=O)N1CCCCCC1)C(=O)NCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Canocapavir
Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.
-
Inarigivir ammonium
Inarigivir ammonium is a dinucleotide antiviral compound that significantly reduces HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir is an agonist of retinoic acid-inducible gene-I (RIG-I) that activates intracellular innate immunity.
-
?-Thujaplicinol
?-Thujaplicinol, a hydroxylated thujaplicinone isolated from western red cedar heartwood, has antiviral activity, inhibits hepatitis B virus replication by blocking viral ribonuclease H activity, and can be used in the study of viral infections.
Cart
sales@molnova.com